All I want for Christmas is ethical, informative trials
Sensible Medicine
DECEMBER 25, 2024
Recently, at the American Society of Hematology and concurrently published in the New England Journal was a randomized controlled trial of treating smoldering myeloma. The investigators congratulated themselves and said there's a new standard of care. But the reality is the trial has fatal flaws, and reflects the failures of our field. Smoldering myeloma is an interesting disease.
52 
Let's personalize your content